Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node

Journal of Experimental Medicine

Volumn 196, Issue 8, 2002, Pages 1079-1090

  Scheinecker, Clemens ^a   McHugh, Rebecca ^a   Shevach, Ethan M ^a   Germain, Ronald N ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antigen presenting cells; Autoantigen; Autoimmune disease; CD11c antigen; Gastritis

Indexed keywords

AUTOANTIGEN; CD11 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GASTRITIS; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOLOGICAL TOLERANCE; LYMPH NODE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH PARIETAL CELL; T LYMPHOCYTE; TISSUE SPECIFICITY;

ANIMALS; AUTOANTIGENS; DENDRITIC CELLS; FEMALE; H(+)-K(+)-EXCHANGING ATPASE; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC;

EID: 0037152162     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020991     Document Type: Article

References (66)

1. von Boehmer, H. 1988. The developmental biology of T lymphocytes. Annu. Rev. Immunol. 6:309-326.
2. Robey, E., and B.J. Fowlkes. 1994. Selective events in T cell development. Annu. Rev. Immunol. 12:675-705.
3. Schwartz, R.H. 1989. Acquisition of immunologic self-tolerance. Cell. 57:1073-1081.
4. Schonrich, G., F. Momburg, M. Malissen, A.M. Schmitt-Verhulst, B. Malissen, G.J. Hämmerling, and B. Arnold. 1992. Distinct mechanisms of extrathymic T-cell tolerance due to differential expression of self antigen. Int. Immunol. 4:581-590.
5. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J.V. Ravetch, R.M. Steinman, and M.C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-779.
6. Banchereau, J., and R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
7. Steinman, R.M., and M.C. Nussenzweig. 2002. Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA. 99:351-358.
8. Reis e Sousa, C., and R.N. Germain. 1999. Analysis of adjuvant function by direct visualization of antigen presentation in vivo: Endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue. J. Immunol. 162:6552-6561.
9. Inaba, K., S. Turley, T. Iyoda, F. Yamaide, S. Shimoyama, C. Reis e Sousa, R.N. Germain, I. Mellman, and R.M. Steinman. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191:927-936.
10. Turley, S.J., K. Inaba, W.S. Garrett, M. Ebersold, J. Unternaehrer, R.M. Steinman, and I. Mellman. 2000. Transport of peptide-MHC class II complexes in developing dendritic cells. Science. 288:522-527.
11. Toh, B.H., J.W. Sentry, and F. Alderuccio. 2000. The causative H+/K+ ATPase antigen in the pathogenesis of autoimmune gastritis. Immunol. Today. 21:348-354.
12. Shevach, E.M. 2000. Suppressor T cells: Rebirth, function and homeostasis. Curr. Biol. 10:R572-R575.
13. Sercarz, E.E., P.V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-766.
14. Suri-Payer, E., A.Z. Amar, R. McHugh, K. Natarajan, D.H. Margulies, and E.M. Shevach. 1999. Post-thymectomy autoimmune gastritis: Fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells. Eur. J. Immunol. 29:669-677.
15. Murphy, K.M., A.B. Heimberger, and D.Y. Loh. 1990. Induction by antigen of intrathymic apoptosis of CD4+ CD8+TCRlo thymocytes in vivo. Science. 250:1720-1723.
16. McHugh, R.S., E.M. Shevach, D.H. Margulies, and K. Natarajan. 2001. A T cell receptor transgenic model of severe, spontaneous organ-specific autoimmunity. Eur. J. Immunol. 31:2094-2103.
17. Metlay, J.P., M.D. Witmer-Pack, R. Agger, M.T. Crowley, D. Lawless, and R.M. Steinman. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171:1753-1771.
18. Suri-Payer, E., P.J. Kehn, A.W. Cheever, and E.M. Shevach. 1996. Pathogenesis of post-thymectomy autoimmune gastritis. Identification of anti-H/K adenosine triphosphatase-reactive T cells. J. Immunol. 157:1799-1805.
19. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
20. Guery, J.C., and L. Adorini. 1995. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J. Immunol. 154:536-544.
21. Dittel, B.N., I. Visintin, R.M. Merchant, and C.A. Janeway, Jr. 1999. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J. Immunol. 163:32-39.
22. Albert, M.L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:86-89.
23. Kurts, C., M. Cannarile, I. Klebba, and T. Brocker. 2001. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166:1439-1442.
24. Aharoni, R., D. Teitelbaum, R. Arnon, and J. Puri. 1991. Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex. Nature. 351:147-150.
25. Murphy, D.B., S. Rath, E. Pizzo, A.Y. Rudensky, A. George, J.K. Larson, and C.A. Janeway, Jr. 1992. Monoclonal antibody detection of a major self peptide-MHC class-II complex. J. Immunol. 148:3483-3491.
26. Puri, J., R. Arnon, E. Gurevich, and D. Teitelbaum. 1997. Modulation of the immune response in multiple sclerosis: Production of monoclonal antibodies specific to HLA/myelin basic protein. J. Immunol. 158:2471-2476.
27. Zhong, G., C. Reis e Sousa, and R.N. Germain. 1997. Production, specificity, and functionality of monoclonal antibodies to specific peptide: MHC class II complexes formed by active processing of exogenous protein. Proc. Natl. Acad. Sci. USA. 94:13856-13861.
28. Dadaglio, G., C.A. Nelson, M.B. Deck, S.J. Petzold, and E.R. Unanue. 1997. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity. 6:727-738.
29. Krogsgaard, M., K.W. Wucherpfennig, B. Canella, B.E. Hansen, A. Svejgaard, J. Pyrdol, H. Ditzel, C. Raine, J. Engberg, and L. Fugger. 2000. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex. J. Exp. Med. 191:1395-1412.
30. Chow, D.C., and J.G. Forte. 1993. Characterization of the β-subunit of the H(+)-K(+)-ATPase using an inhibitory monoclonal antibody. Am. J. Physiol. 265:C1562-C1570.
31. Inaba, K., S. Turley, F. Yamaide, T. Iyoda, K. Mahnke, M. Inaba, M. Pack, M. Subklewe, B. Sauter, D. Sheff, et al. 1998. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188:2163-2173.
32. Crowley, M., K. Inaba, and R.M. Steinman. 1990. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J. Exp. Med. 172:383-386.
33. Romani, N., S. Koide, M. Crowley, M. Witmer-Pack, A.M. Livingstone, C.G. Fathman, K. Inaba, and R.M. Steinman. 1989. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169:1169-1178.
34. Pure, E., K. Inaba, M.T. Crowley, L. Tardelli, M.D. Witmer-Pack, G. Ruberti, G. Fathman, and R.M. Steinman. 1990. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J. Exp. Med. 172:1459-1469.
35. Reis e Sousa, C., P.D. Stahl, and J.M. Austyn. 1993. Phagocytosis of antigens by Langerhans cells in vitro. J. Exp. Med. 178:509-519.
36. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by ganulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
37. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: Endogenous activators of dendritic cells. Nat. Med. 5:1249-1255.
38. McCoy, K.L., J. Miller, M. Jenkins, F. Ronchese, R.N. Germain, and R.H. Schwartz. 1989. Diminished antigen processing by endosomal acidification mutant antigen-presenting cells. J. Immunol. 143:29-38.
39. Stockinger, B., U. Pessara, R.H. Lin, J. Habicht, M. Grez, and N. Koch. 1989. A role of Ia-associated invariant chains in antigen processing and presentation. Cell. 56:683-689.
40. Ardavin, C., L. Wu, C.L. Li, and K. Shortman. 1993. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature. 362:761-763.
41. Wu, L., C.L. Li, and K. Shortman. 1996. Thymic dendritic cell precursors: Relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny. J. Exp. Med. 184:903-911.
42. Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs: Cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159:565-573.
43. de St Groth, B.F. 1998. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol. Today. 19:448-454.
44. de St Groth, B.F. 2001. DCs and peripheral T cell tolerance. Semin. Immunol. 13:311-322.
45. Guery, J.C., F. Ria, F. Galbiati, S. Smiroldo, and L. Adorini. 1997. The mode of protein antigen administration determines preferential presentation of peptide-class II complexes by lymph node dendritic or B cells. Int. Immunol. 9:9-15.
46. Zhong, G., C. Reis e Sousa, and R.N. Germain. 1997. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro. J. Exp. Med. 186:673-682.
47. Cassell, D.J., and R.H. Schwartz. 1994. A quantitative analysis of antigen-presenting cell function: Activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J. Exp. Med. 180:1829-1840.
48. Miller, S.D., B.L. McRae, C.L. Vanderlugt, K.M. Nikcevich, J.G. Pope, L. Pope, and W.J. Karpus. 1995. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol. Rev. 144:225-244.
49. Mamula, M.J. 1998. Epitope spreading: The role of self peptides and autoantigen processing by B lymphocytes. Immunol. Rev. 164:231-239.
50. Judd, L.M., P.A. Gleeson, B.H. Toh, and I.R. van Driel. 1999. Autoimmune gastritis results in disruption of gastric epithelial cell development. Am. J. Physiol. 277:G209-G218.
51. Grabbe, S., R.L. Gallo, A. Lindgren, and R.D. Granstein. 1993. Deficient antigen presentation by Langerhans cells from athymic (nu/nu) mice. Restoration with thymic transplantation or administration of cytokines. J. Immunol. 151:3430-3439.
52. Burkly, L., C. Hession, L. Ogata, C. Reilly, L.A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 373:531-536.
53. Shreedhar, V., A.M. Moodycliffe, S.E. Ullrich, C. Bucana, M.L. Kripke, and L. Flores-Romo. 1999. Dendritic cells require T cells for functional maturation in vivo. Immunity. 11:625-636.
54. Shortman, K., and Y.J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-161.
55. Suss, G., and K. Shortman. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183:1789-1796.
56. Kronin, V., K. Winkel, G. Suss, A. Kelso, W. Heath, J. Kirberg, H. von Boehmer, and K. Shortman. 1996. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J. Immunol. 157:3819-3827.
57. Inaba, K., M. Pack, M. Inaba, H. Sakuta, F. Isdell, and R.M. Steinman. 1997. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 186:665-672.
58. Kronin, V., C.J. Fitzmaurice, I. Caminschi, K. Shortman, D.C. Jackson, and L.E. Brown. 2001. Differential effect of CD8(+) and CD8(-) dendritic cells in the stimulation of secondary CD4(+) T cells. Int. Immunol. 13:465-473.
59. Hugues, S., E. Mougneau, W. Ferlin, D. Jeske, P. Hofman, D. Homann, L. Beaudoin, C. Schrike, M. Von Herrath, A. Lehuen, et al. 2002. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity. 16:169-181.
60. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195:1289-1302.
61. Merad, M., L. Fong, J. Bogenberger, and E.G. Engleman. 2000. Differentiation of myeloid dendritic cells into CD8α-positive dendritic cells in vivo. Blood. 96:1865-1872.
62. Traver, D., K. Akashi, M. Manz, M. Merad, T. Miyamoto, E.G. Engleman, and I.L. Weissman. 2000. Development of CD8α-positive dendritic cells from a common myeloid progenitor. Science. 290:2152-2154.
63. del Hoyo, G.M., P. Martin, C.F. Arias, A.K. Marin, and C. Ardavin. 2002. CD8 α (+) dendritic cells originate from the CD8 α (-) dendritic cell subset by a maturation process involving CD8 α, DEC-205, and CD24 up-regulation. Blood. 99:999-1004.
64. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387-396.
65. Stockinger, B. 1999. T lymphocyte tolerance: From thymic deletion to peripheral control mechanisms. Adv. Immunol. 71:229-265.
66. Morgan, D.J., H.T. Kreuwel, and L.A. Sherman. 1999. Antigen concentration and precursor frequency determine the rate of CD8- T cell tolerance to peripherally expressed antigens. J. Immunol. 163:723-727.